Genetics

Results highlight the importance of routine cancer screenings, suggest genetic testing should go beyond high-risk groups

Current rapid genomic sequencing takes days, but critical NICU decisions often can't wait hours

Automated NGS reduces complexity and cost, enabling community hospitals to expand testing without major infrastructure investments

The National Comprehensive Cancer Network expands its interactive library of expert cancer care guidance to cover over a dozen cancer types and hereditary risk assessment

The work applies a method called local ancestry inference (LAI), which provides more accurate insights into genetic differences

Recommendations by multidisciplinary panel published in the Journal of Pediatrics leverage evidence-based approaches to accelerate diagnosis of familial hypercholesterolemia

MIT researchers have dramatically lowered the error rate of prime editing, a technique that holds potential for treating many genetic disorders

In preclinical models, the CRISPR-Cas9 gene therapy precisely repaired the genetic error that causes a rare vascular disease

AI model uses common data to gauge risk from rare genetic variants

Findings underscore the importance of matched tumor–blood sequencing to avoid diagnostic errors in oncology

Geneseeq’s CanScan® test demonstrated 93 percent early-stage detection and a 98 percent specificity rate in a 3,700-person cohort

The group of genetic conditions is still not widely recognized by healthcare providers, despite decades of research

New gene therapy well-tolerated and improves hearing in all 10 patients with congenital deafness or severe hearing impairment

Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions

New findings could lead to improved immunotherapy options for male patients

White glove manufacturing service aims to enhance design-build-test cycle and drive rapid innovation

Detecting cancers years before their clinical diagnosis could help provide management with a more favorable outcome

Genetic factors contribute to some 30 percent of breast cancer cases in South Africa, necessitating investment in genomic research in African contexts

The new workflow enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development, and precision medicine

Direct in sample sequencing, or DISS, is a high-demand and transformative technology that unlocks library-prep free research possibilities across a variety of new use cases